RNA primed SMAR-T cell therapy / Geneius Biotech - LARVOL DELTA

Geneius Biotechnology Announces Poster Presentation at the 2023 AACR Annual Meeting (PRNewswire) - "Geneius Biotechnology...announced the company will present a poster presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting, taking place April 14-19, 2023, in Orlando, Florida....Poster will feature RNA primed SMAR-T™ cells against multiple cancer driver mutations....Our key product is SMAR-T™ targeting solid tumors starting with Melanoma, Lung and Pancreatic cancer. We collaborate with Yale (CT) and Mount Sinai (NY/NJ) to conduct clinical trials and phase I manufacturing with clinical data anticipated in 2024."

Clinical data • Licensing / partnership • Preclinical • Gastrointestinal Cancer • Lung Cancer • Melanoma • Oncology • Pancreatic Cancer • Skin Cancer • Solid Tumor • Thoracic Cancer